Literature DB >> 6502196

Medulloblastoma metastatic to the marrow. Report of four cases and review of the literature.

C D Spencer, R B Weiss, J Van Eys, P Cohen, B Edwards.   

Abstract

Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally. The skeleton is the most common site of extraneural metastases, but metastases to the bone marrow can also occur. Four cases of medulloblastoma metastatic to the marrow are reported. In addition, 31 cases from the medical literature are reviewed. Clinical features include bone tenderness, cytopenias and elevated serum alkaline phosphatase and lactic dehydrogenase levels. Skeletal involvement, especially of the pelvic bones, is frequently seen radiographically. Weight loss, soft tissue masses and a requirement for blood transfusion are also associated features. Marrow biopsy specimens are characterized by the presence of a small cell tumor often with fibrosis, necrosis and osteoblastic activity. The symptomatic response to chemotherapy is rapid, but chemotherapy resistance appears quickly. Only 1 in 4 cases diagnosed antemortem in this review lived for more than a year. We conclude that marrow aspiration and biopsy are indicated in the evaluation of patients with medulloblastoma and may serve to diagnose the cause of cytopenias, to verify extraneural spread and to provide prognostic information.

Entities:  

Mesh:

Year:  1984        PMID: 6502196     DOI: 10.1007/bf00253274

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  MEDULLOBLASTOMA WITH EXTRACRANIAL METASTASES.

Authors:  D A DRACHMAN; T S WINTER; M KARON
Journal:  Arch Neurol       Date:  1963-11

2.  Distant metastases from medulloblastoma of the cerebellum.

Authors:  E PATERSON
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

3.  Chemotherapy of childhood medulloblastoma.

Authors:  W M Crist; A H Ragab; T J Vietti; R Ducos; J Y Chu
Journal:  Am J Dis Child       Date:  1976-06

Review 4.  The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature.

Authors:  B H Liwnicz; L J Rubinstein
Journal:  Hum Pathol       Date:  1979-07       Impact factor: 3.466

5.  Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group.

Authors:  J Z Finklestein; M R Klemperer; A Evans; I Bernstein; S Leikin; S McCreadie; J Grosfeld; R Hittle; J Weiner; H Sather; D Hammond
Journal:  Med Pediatr Oncol       Date:  1979

6.  Metastatic medulloblastoma simulating acute leukemia.

Authors:  J Y Chu
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

7.  Extraneural metastases in childhood brain tumors.

Authors:  P K Duffner; M E Cohen
Journal:  Ann Neurol       Date:  1981-09       Impact factor: 10.422

8.  Extraneural metastatic medulloblastoma during childhood.

Authors:  J G McComb; R L Davis; H Isaacs
Journal:  Neurosurgery       Date:  1981-11       Impact factor: 4.654

9.  Metastasizing neuroectodermal tumour.

Authors:  I Morild; S Mørk; H Nyland
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

10.  High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.

Authors:  J C Allen; L Helson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

View more
  3 in total

Review 1.  Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors:  P M Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

2.  Extraneural metastatic medulloblastoma in an adult.

Authors:  Merideth M Wendland; Dennis C Shrieve; Gordon A Watson; Steven S Chin; Deborah T Blumenthal
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

3.  Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis.

Authors:  T Tomita; L Das; M A Radkowski
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.